Scientists have got success with a new injection of HIV. Taking this injection once a year can reduce the risk of HIV ...
In the slightly different system of the CDC, it is also described as stage 1 (but defined in terms of a CD4 cell count above 500). ‘Asymptomatic’ means ‘without symptoms’. It does not mean HIV is not ...
Gilead said two experimental once-a-year versions of its HIV prevention shot lenacapavir passed muster in an early-stage ...
Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...
The OraQuick Advance Rapid HIV-1 Antibody Test has transformed HIV testing ... A new case report now highlights the test's fallibility in late-stage AIDS. A 28-year-old man came to a Michigan ...
Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...
The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...
ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...
HIV is a virus. It may cause AIDS after you’ve been infected for several years and it’s weakened your immune system. HIV doesn’t affect everyone the same way. Some people notice signs soon ...